BEST UNLIMITED TURBO LONG CERTIFICATE - PFIZER INC | Real-time Borsa Italiana 04:53:18 2024-06-28 am EDT | ||
| 1.361 EUR | +3.03% |
|
| Current month | -41.81% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 1.361 | +3.03% |
| 24-06-27 | 1.321 | +32.23% |
| 24-06-26 | 0.999 | -34.28% |
| 24-06-25 | 1.52 | -16.48% |
| 24-06-24 | 1.82 | +39.68% |
Real-time Borsa Italiana
Last update June 28, 2024 at 04:53 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Société Générale
|
| S36187 | |
| ISIN | DE000SY0TSX3 |
| Date issued | 2024-05-28 |
| Strike | 26.52 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.18 € |
|---|---|
| Lowest since issue | 0.573 € |
| Spread | 0.12 € |
| Spread % | 8.47% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.8
USD
Average target price
31.92
USD
Spread / Average Target
+14.80%
- Stock Market
- Certificates
- S36187 Certificat
